Is cancer gene therapy an empty suit?

被引：46

作者：

Brenner, Malcolm K. ^{[1
,2
,3
,4
]}

Gottschalk, Stephen ^{[1
,2
,3
,5
]}

Leen, Ann M. ^{[1
,2
,3
,5
]}

Vera, Juan F. ^{[1
,2
,4
]}

机构：

[1] Baylor Coll Med, Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA

[2] Texas Childrens Hosp, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[4] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[5] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA

来源：

LANCET ONCOLOGY | 2013年 / 14卷 / 11期

基金：

美国国家卫生研究院;

关键词：

PLASMID DNA VACCINE; T-CELL-RECEPTORS; DENDRITIC CELLS; CLINICAL-TRIAL; PHASE-I; SUICIDE-GENE; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; DONOR LYMPHOCYTES; MELANOMA PATIENTS;

D O I：

10.1016/S1470-2045(13)70173-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gene therapy as a treatment for cancer is regarded as high in promise, but low in delivery, a deficiency that has become more obvious with ever-increasing reports of the successful correction of monogenic disorders by this approach. We review the commercial and scientific obstacles that have led to these delays and describe how they are progressively being overcome. Recent and striking successes and correspondingly increased commercial involvement suggest that gene transfer could finally become a powerful method for development of safe and effective cancer therapeutic drugs.

引用

页码：E447 / E456

页数：10

共 74 条

[1] Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy [J].

Adair, Jennifer E. ;

Beard, Brian C. ;

Trobridge, Grant D. ;

Neff, Tobias ;

Rockhill, Jason K. ;

Silbergeld, Daniel L. ;

Mrugala, Maciej M. ;

Kiem, Hans-Peter .

SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (133)

[2] Progress on new vaccine strategies for the immunotherapy and prevention of cancer [J].

Berzofsky, JA ;

Terabe, M ;

Oh, SK ;

Belyakov, IM ;

Ahlers, JD ;

Janik, JE ;

Morris, JC .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1515-1525

[3] Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia [J].

Biagi, E ;

Rousseau, R ;

Yvon, E ;

Schwartz, M ;

Dotti, G ;

Foster, A ;

Havlik-Cooper, D ;

Grilley, B ;

Gee, A ;

Baker, K ;

Carrum, G ;

Rice, L ;

Andreeff, M ;

Popat, U ;

Brenner, M .

CLINICAL CANCER RESEARCH, 2005, 11 (19) :6916-6923

[4] Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].

Boczkowski, D ;

Nair, SK ;

Snyder, D ;

Gilboa, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472

[5]

Bollard CM, 2012, MOL THER, V20, pS22

[6] Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity [J].

Bollard, CM ;

Rössig, C ;

Calonge, MJ ;

Huls, MH ;

Wagner, HJ ;

Massague, J ;

Brenner, MK ;

Heslop, HE ;

Rooney, CM .

BLOOD, 2002, 99 (09) :3179-3187

[7] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[8] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].

Brentjens, Renier J. ;

Riviere, Isabelle ;

Park, Jae H. ;

Davila, Marco L. ;

Wang, Xiuyan ;

Stefanski, Jolanta ;

Taylor, Clare ;

Yeh, Raymond ;

Bartido, Shirley ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Bernal, Yvette ;

Pegram, Hollie ;

Przybylowski, Mark ;

Hollyman, Daniel ;

Usachenko, Yelena ;

Pirraglia, Domenick ;

Hosey, James ;

Santos, Elmer ;

Halton, Elizabeth ;

Maslak, Peter ;

Scheinberg, David ;

Jurcic, Joseph ;

Heaney, Mark ;

Heller, Glenn ;

Frattini, Mark ;

Sadelain, Michel .

BLOOD, 2011, 118 (18) :4817-4828

[9] Do CARs Need a Driver's License? Adoptive Cell Therapy with Chimeric Antigen Receptor-Redirected T Cells Has Caused Serious Adverse Events [J].

Buening, Hildegard ;

Uckert, Wolfgang ;

Cichutek, Klaus ;

Hawkins, Robert E. ;

Abken, Hinrich .

HUMAN GENE THERAPY, 2010, 21 (09) :1039-1042

[10]

Cavazzana-Calvo M, 2012, CURR OPIN IMMUNOL, V24, P580, DOI 10.1016/j.coi.2012.08.008

← 1 2 3 4 5 6 7 8 →